期刊
NEUROIMAGE
卷 61, 期 4, 页码 1402-1418出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2012.02.084
关键词
Unbiased longitudinal image processing; MRI biomarkers; Reliability and power; Within-subject template; FreeSurfer
资金
- National Center for Research Resources [P41RR14075]
- NCRR BIRN [BIRN002, U24RR021382]
- National Institute for Biomedical Imaging and Bioengineering [R01EB006758]
- National Institute on Aging [R01AG022381, U01AG024904]
- National Institute for Neurological Disorders and Stroke [R01NS052585, R01NS042861, P01NS058793, R21NS072652, R01NS070963]
- Ellison Medical Foundation
- National Center for Alternative Medicine [RC1AT005728]
- [S10RR023401]
- [S10RR019307]
- [S10RR023043]
- [P50AG05681]
- [P01AG03991]
- [R01AG021910]
- [P50MH071616]
- [R01MH56584]
Longitudinal image analysis has become increasingly important in clinical studies of normal aging and neurodegenerative disorders. Furthermore, there is a growing appreciation of the potential utility of longitudinally acquired structural images and reliable image processing to evaluate disease modifying therapies. Challenges have been related to the variability that is inherent in the available cross-sectional processing tools, to the introduction of bias in longitudinal processing and to potential over-regularization. In this paper we introduce a novel longitudinal image processing framework, based on unbiased, robust, within-subject template creation, for automatic surface reconstruction and segmentation of brain MRI of arbitrarily many time points. We demonstrate that it is essential to treat all input images exactly the same as removing only interpolation asymmetries is not sufficient to remove processing bias. We successfully reduce variability and avoid over-regularization by initializing the processing in each time point with common information from the subject template. The presented results show a significant increase in precision and discrimination power while preserving the ability to detect large anatomical deviations; as such they hold great potential in clinical applications, e.g. allowing for smaller sample sizes or shorter trials to establish disease specific biomarkers or to quantify drug effects. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据